4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-22-077380
Options or other derivatives
- Director acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ben Zvi Shmuel Director | 2022-06-30 | Grant or award · Stock Options (Right to Buy) | +40,000 | 40,000 | D | ||
Loading xslF345X03/tm2220369-1_4seq1.xml…